In children two years or older with mild acute otitis media symptoms, which management is acceptable?

In children two years or older with mild acute otitis media symptoms, which management is acceptable?

• A. Observation with follow-up in 3 months
• B. Immediate antibiotics
• C. Oral antibiotics for 5 days
• D. Intravenous antibiotics

Answer: (A)

Watchful waiting is a reasonable approach for mild acute otitis media in children age two years and older. Many mild cases improve on their own within a couple of days, so starting with analgesia for pain and observing the child—with a plan to reassess in about 48 to 72 hours—avoids unnecessary antibiotic use and its side effects. Antibiotics provide only a modest short-term benefit for pain in this group and carry risks such as diarrhea, rash, and antibiotic resistance. If the child develops higher fever, more severe ear pain, bilaterally affected ears, signs of systemic illness, or fails to improve or worsens over the next 48–72 hours, then starting antibiotics would be appropriate. Intravenous antibiotics aren’t indicated for outpatient, mild disease. Similarly, delaying care with a follow-up far beyond a few days isn’t advisable; a 3-month follow-up would miss a potential progression that would warrant treatment.

Watchful waiting is a reasonable approach for mild acute otitis media in children age two years and older. Many mild cases improve on their own within a couple of days, so starting with analgesia for pain and observing the child—with a plan to reassess in about 48 to 72 hours—avoids unnecessary antibiotic use and its side effects. Antibiotics provide only a modest short-term benefit for pain in this group and carry risks such as diarrhea, rash, and antibiotic resistance.

If the child develops higher fever, more severe ear pain, bilaterally affected ears, signs of systemic illness, or fails to improve or worsens over the next 48–72 hours, then starting antibiotics would be appropriate. Intravenous antibiotics aren’t indicated for outpatient, mild disease. Similarly, delaying care with a follow-up far beyond a few days isn’t advisable; a 3-month follow-up would miss a potential progression that would warrant treatment.